| Period Ending: |
LTM
(Last Twelve Months) |
2022 12-31 |
2021 12-31 |
|---|---|---|---|
| Report Filing | 2023-04-13 | 2023-04-13 | 2022-03-31 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | -0.327 | 0 | 0 |
| Operating Expenses | 1.45 | 1.78 | 1.17 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | 2.78 | 0 | 0 |
| Other Operating Expenses | -1.32 | 1.78 | 1.17 |
| Operating Income | -1.78 | -1.78 | -1.17 |
| Net Non-Operating Interest | -12.01 | 3.06 | 6.36 |
| Interest Income | 3.07 | 3.06 | 0 |
| Interest Expense | 15.07 | 0 | -6.36 |
| Equity & Other Income/(Expense) | 26.12 | 11.05 | 0 |
| Income Before Tax | 12.33 | 12.33 | 5.2 |
| Income Tax Expense | -14.11 | -14.11 | -6.36 |
| Income Attributable to Non-Controlling Interest | -0.001 | 0 | 0 |
| Net Income | 26.44 | 26.44 | 11.56 |
| Depreciation and Amortization | -11.05 | -11.05 | 6.36 |
| EBITDA | -12.83 | -12.83 | 5.2 |
| Earnings Per Share (EPS) | 1.12 | 1.32 | 0.46 |
| Diluted Earnings Per Share | 1.12 | 1.32 | 0.46 |
| Weighted Average Shares Outstanding | 20.01 | 20.01 | 25.01 |
| Diluted Weighted Average Shares Outstanding | 20.01 | 20.01 | 25.01 |
